Acidic alpha-D-mannosidase in phenotypically different leukemic lymphoid cells. 1992

N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
Institute of Biological and Medical Chemistry, Russian Academy of Medical Sciences, Moscow.

The activity of acid alpha-mannosidase in phenotypically characterized lymphoid cells, isolated from peripheral blood, spleen and lymph nodes of patients with various lymphoproliferative disorders has been studied. Cells with different immunophenotypes were shown to have different alpha-mannosidase activity levels. The lowest alpha-mannosidase activity was observed in cells phenotypically corresponding to early B cells obtained from B-CLL patients. The highest activity was determined in cells with phenotypes of activated, CD11c-expressing B cells from B-NHL and HCL patients. There were considerable differences in alpha-mannosidase activity between peripheral blood and spleen lymphoid cells of B-NHL patients with spleen damage. The data obtained may be used in classification, primary diagnosis and staging of hematopoietic malignancies.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D008361 Mannosidases Glycoside hydrolases that catalyze the hydrolysis of alpha or beta linked MANNOSE. Mannosidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D043323 alpha-Mannosidase An enzyme that catalyzes the HYDROLYSIS of terminal, non-reducing alpha-D-mannose residues in alpha-D-mannosides. The enzyme plays a role in the processing of newly formed N-glycans and in degradation of mature GLYCOPROTEINS. There are multiple isoforms of alpha-mannosidase, each having its own specific cellular location and pH optimum. Defects in the lysosomal form of the enzyme results in a buildup of mannoside intermediate metabolites and the disease ALPHA-MANNOSIDOSIS. Lysosomal alpha-Mannosidase,LAMAN,Neutral alpha-Mannosidase,alpha Mannosidase B,alpha-D-Mannosidase,alpha-D-Mannoside Mannohydrolase,Lysosomal alpha Mannosidase,Mannohydrolase, alpha-D-Mannoside,Mannosidase B, alpha,Neutral alpha Mannosidase,alpha D Mannosidase,alpha D Mannoside Mannohydrolase,alpha Mannosidase,alpha-Mannosidase, Lysosomal,alpha-Mannosidase, Neutral

Related Publications

N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
January 1982, Enzyme,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
August 1991, Biokhimiia (Moscow, Russia),
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
June 1983, Hiroshima journal of medical sciences,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
June 1980, Clinica chimica acta; international journal of clinical chemistry,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
June 1999, Bioscience reports,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
September 1975, Virchows Archiv. B, Cell pathology,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
August 1966, Archives of biochemistry and biophysics,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
August 1974, Clinica chimica acta; international journal of clinical chemistry,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
January 1984, The International journal of biochemistry,
N A Ushakova, and R S Samojlova, and M E Preobrazhenskaya
December 1977, Virchows Archiv. B, Cell pathology,
Copied contents to your clipboard!